Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by JPPOUGET
Group name EquipeJPP
Item Type Journal Article
Title The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study
Creator van der Weijst et al.
Author David Azria
Author Patrick Berkovic
Author Pierre Boisselier
Author Erik Briers
Author Renée Bultijnck
Author Jenny Chang-Claude
Author Ananya Choudhury
Author Gilles Defraene
Author Sylvian Demontois
Author Rebecca M. Elliott
Author Dawn Ennis
Author Corinne Faivre-Finn
Author Marzia Franceschini
Author Tommaso Giandini
Author Alexandra Giraldo
Author Sara Gutiérrez-Enríquez
Author Carsten Herskind
Author Daniel S. Higginson
Author Sarah L. Kerns
Author Kerstie Johnson
Author Maarten Lambrecht
Author Philippe Lang
Author Mónica Ramos
Author Tiziana Rancati
Author Andreas Rimner
Author Barry S. Rosenstein
Author Dirk De Ruysscher
Author Ahmed Salem
Author Claudia Sangalli
Author Petra Seibold
Author Paloma Sosa Fajardo
Author Elena Sperk
Author Hilary Stobart
Author Holly Summersgill
Author Veerle Surmont
Author Paul Symonds
Author Begoña Taboada-Valladares
Author Christopher J. Talbot
Author Ana Vega
Author Liv Veldeman
Author Marlon R. Veldwijk
Author Tim Ward
Author Adam Webb
Author Catharine M. L. West
Author Yolande Lievens
Abstract BACKGROUND AND PURPOSE: To investigate the association between clinician-scored toxicities and patient-reported health-related quality of life (HRQoL), in early-stage (ES-) and locally-advanced (LA-) non-small cell lung cancer (NSCLC) patients receiving loco-regional radiotherapy, included in the international real-world REQUITE study. MATERIALS AND METHODS: Clinicians scored eleven radiotherapy-related toxicities (and baseline symptoms) with the Common Terminology Criteria for Adverse Events version 4. HRQoL was assessed with the European Organization for Research and Treatment of Cancer core HRQoL questionnaire (EORTC-QLQ-C30). Statistical analyses used the mixed-model method; statistical significance was set at p = 0.01. Analyses were performed for baseline and subsequent time points up to 2 years after radiotherapy and per treatment modality, radiotherapy technique and disease stage. RESULTS: Data of 435 patients were analysed. Pre-treatment, overall symptoms, dyspnea, chest wall pain, dysphagia and cough impacted overall HRQoL and specific domains. At subsequent time points, cough and dysphagia were overtaken by pericarditis in affecting HRQoL. Toxicities during concurrent chemo-radiotherapy and 3-dimensional radiotherapy had the most impact on HRQoL. Conversely, toxicities in sequential chemo-radiotherapy and SBRT had limited impact on patients' HRQoL. Stage impacts the correlations: LA-NSCLC patients are more adversely affected by toxicity than ES-NSCLC patients, mimicking the results of radiotherapy technique and treatment modality. CONCLUSION: Pre-treatment symptoms and acute/late toxicities variously impact HRQoL of ES- and LA-NSCLC patients undergoing different treatment approaches and radiotherapy techniques. Throughout the disease, dyspnea seems crucial in this association, highlighting the additional effect of co-existing comorbidities. Our data call for optimized radiotherapy limiting toxicities that may affect patients' HRQoL.
Publication Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology
Volume 176
Pages 127-137
Date 2022-11
Journal Abbr Radiother Oncol
Language eng
DOI 10.1016/j.radonc.2022.09.020
ISSN 1879-0887
Short Title The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients
Library Catalog PubMed
Extra PMID: 36195214 PMCID: PMC10404651
Tags Association, Carcinoma, Non-Small-Cell Lung, clinic, Cough, Deglutition Disorders, Dyspnea, Humans, Lung Neoplasms, Non-small cell lung cancer, Patient Reported Outcome Measures, Patient-reported outcomes, Quality of Life, Radiation Injuries, Radiotherapy, Toxicity
Date Added 2023/11/23 - 12:48:40
Date Modified 2023/11/23 - 12:48:40
Notes and Attachments PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés